Theragen Etex Co.Ltd
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company wa… Read more
Theragen Etex Co.Ltd (066700) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.023x
Based on the latest financial reports, Theragen Etex Co.Ltd (066700) has a cash flow conversion efficiency ratio of 0.023x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.35 Billion) by net assets (₩145.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Theragen Etex Co.Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Theragen Etex Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Theragen Etex Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Theragen Etex Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Cakra Buana Resources Energ
JK:CBRE
|
-0.549x |
|
Jagran Prakashan Limited
NSE:JAGRAN
|
0.060x |
|
Tri Ocean Textile Co Ltd
TW:1472
|
-0.066x |
|
Electra Battery Materials Corp
NASDAQ:ELBM
|
-0.046x |
|
Zhejiang Taimei Medical Technology Co., Ltd.
F:A2V
|
-0.017x |
|
Treasury Metals Inc
F:TRC1
|
-0.041x |
|
Wielton S.A.
WAR:WLT
|
-0.070x |
|
Mayfield Group Holdings Ltd
AU:MYG
|
0.339x |
Annual Cash Flow Conversion Efficiency for Theragen Etex Co.Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Theragen Etex Co.Ltd from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩130.54 Billion | ₩1.79 Billion | 0.014x | -82.72% |
| 2023-12-31 | ₩152.93 Billion | ₩12.12 Billion | 0.079x | +18.67% |
| 2022-12-31 | ₩143.60 Billion | ₩9.59 Billion | 0.067x | +271.32% |
| 2021-12-31 | ₩222.70 Billion | ₩4.01 Billion | 0.018x | -49.11% |
| 2020-12-31 | ₩374.12 Billion | ₩13.23 Billion | 0.035x | +12645.45% |
| 2019-12-31 | ₩135.86 Billion | ₩37.69 Million | 0.000x | +100.12% |
| 2018-12-31 | ₩80.92 Billion | ₩-18.58 Billion | -0.230x | -1223.09% |
| 2017-12-31 | ₩86.93 Billion | ₩1.78 Billion | 0.020x | +117.59% |
| 2016-12-31 | ₩72.10 Billion | ₩-8.38 Billion | -0.116x | -1825.75% |
| 2015-12-31 | ₩68.82 Billion | ₩-415.37 Million | -0.006x | -1338.61% |
| 2014-12-31 | ₩82.00 Billion | ₩39.95 Million | 0.000x | -99.59% |
| 2008-12-31 | ₩26.20 Billion | ₩3.14 Billion | 0.120x | -- |